Arab countries - Asia - Australia - Australia, New Zealand - Austria, Germany - Canada - Canada, United States - China - Denmark - Europe - France - Germany - High-income countries - India - International - Ireland - Israel - Italy - Japan - Latin America - Low and middle income countries - Malaysia - New Zealand - Norway - Poland - Republic of Korea - Republic of Korea, United States - Saudi Arabia - Sweden - United Kingdom - United States - WHO - {Related topics}

Arab countries

• Frontiers in Global Women's Health
  • Utilisation of hormone replacement therapy in Arab countries: a systematic review [2026]

Asia

• Climacteric
  • Updated clinical recommendations for the use of tibolone in Asian women [2010]

Australia

• Australasian Menopause Society
  • AMS Guide to MHT/HRT Doses Australia only

• Australian and New Zealand Journal of Obstetrics and Gynaecology
  • Trends in Government-Subsidised Menopausal Hormone Therapy Dispensing in Australia Between 2014 and 2023 [2026]

• Australian Journal of General Practice
  • The menopause consultation [2026]
  • Demystifying menopausal hormone therapy prescribing [2026]
  • Making choices at menopause [2019]

• Australian Prescriber
  • Management of menopause [2023]

• BMC Women's Health
  • Menopause and the influence of culture: another gap for Indigenous Australian women? [2012]

• Royal Australian College of General Practitioners
  • Postmenopause

Australia, New Zealand

• Australasian Menopause Society
  • Health Professionals

• Royal Australian and New Zealand College of Obstetricians and Gynaecologists
  • Managing menopausal symptoms [2020]

Austria, Germany

• Geburtshilfe und Frauenheilkunde
  • Perimenopause and Postmenopause – Diagnosis and Interventions. Guideline of the DGGG and OEGGG (S3-Level, AWMF Registry Number 015-062, September 2020) [2021]

Canada

• Canada's Drug Agency
  • Oral Progesterone for the Treatment of Menopausal Symptoms: A Review of the Clinical Evidence [2014]

• Canadian Menopause Society
  • Publications

• CMAJ
  • A pragmatic approach to the management of menopause [2023]

• Society of Obstetricians and Gynaecologists of Canada
  • SOGC Guidelines Collection: Managing Menopause
  • Menopause

Canada, United States

• Menopause Society
  • The 2022 hormone therapy position statement of The North American Menopause Society [2022]
  • Position Statements

China

• Journal of Medical Economics
  • Evaluating the cost utility of estradiol plus dydrogesterone for the treatment of menopausal women in China [2024]

• Menopause
  • Prevalence and risk factors for menopausal symptoms in middle-aged Chinese women: a community-based cross-sectional study [2021]

Denmark

• BMJ
  • Menopausal hormone therapy and long term mortality: nationwide, register based cohort study [2026]

Europe

• European AIDS Clinical Society
  • Management of menopause in women living with HIV - A comparative guideline review [2024]
  • Collection of menopause data in studies of women living with HIV: A systematic literature review [2024]

• European Menopause and Andropause Society
  • Chronic kidney disease and menopausal health: An EMAS clinical guide [2025]
  • EMAS position statement: Thyroid disease and menopause [2024]
  • The essential menopause curriculum for healthcare professionals: A European Menopause and Andropause Society (EMAS) position statement [2022]
  • Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society [2022]
  • Global consensus recommendations on menopause in the workplace: A European Menopause and Andropause Society (EMAS) position statement [2021]
  • The Mediterranean diet and menopausal health: An EMAS position statement [2020]
  • Menopause and diabetes: EMAS clinical guide [2018]
  • A model of care for healthy menopause and ageing: EMAS position statement [2016]
  • EMAS position statement: The ten point guide to the integral management of menopausal health [2015]
  • Guidelines and education

• European Society of Endocrinology
  • European society of endocrinology clinical practice guideline for evaluation and management of menopause and the perimenopause [2025]

• Maturitas
  • Persistent gaps in menopause care: current recommendations of the POESIT group [2025]

France

• Collège National des Gynécologues et Obstétriciens Français
  • Management of postmenopausal women: Collège National des Gynécologues et Obstétriciens Français (CNGOF) and Groupe d'Etude sur la Ménopause et le Vieillissement (GEMVi) Clinical Practice Guidelines [2022]

Germany

• Archives of Gynecology and Obstetrics
  • Peri- and postmenopause—diagnosis and interventions interdisciplinary S3 guideline of the association of the scientific medical societies in Germany (AWMF 015/062): short version [2020]
  • Hormone therapy in perimenopause and postmenopause (HT). Interdisciplinary S3 Guideline, Association of the Scientific Medical Societies in Germany AWMF 015/062-short version [2011]

• Deutsches Ärzteblatt International
  • The Treatment of Climacteric Symptoms [2012]

High-income countries

• Medicina
  • Menopausal Hormone Therapy in Clinically Vulnerable Women: A Narrative Review of Guidelines and Real-World Evidence [2026]

India

• Indian Menopause Society
  • Clinical Practice Guidelines on Menopause and Postmenopausal Osteoporosis [2020]
  • Information for Professionals

International

• BioScience Trends
  • Update on hormone therapy for the management of postmenopausal women [2022]

• BMC Public Health
  • Mapping global prevalence of menopausal symptoms among middle-aged women: a systematic review and meta-analysis [2024]

• BMC Women's Health
  • Indigenous women's experiences, symptomology and understandings of menopause: a scoping review [2025]

• Bulletin of the World Health Organization
  • Towards a more accurate global picture of perimenopause [2024]

• Climacteric
  • The 2023 Practitioner's Toolkit for Managing Menopause [2023]
  • Global Consensus Statement on Menopausal Hormone Therapy [2013]

• European Journal of Obstetrics & Gynecology and Reproductive Biology
  • A quality assessment and systematic review of clinical practice guidelines on hormone replacement therapy for menopause using the AGREE II instrument [2024]

• European Menopause and Andropause Society
  • European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis [2020]

• Fertility and Sterility
  • Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging [2012]

• Frontiers in Public Health
  • Menopausal transitional and postmenopausal women's voices: "what influences their adherence to self-management": a systematic review and meta-synthesis of qualitative studies [2025]

• Health Promotion International
  • Women's experiences and expectations during the menopause transition: a systematic qualitative narrative review [2025]

• International Federation of Gynecology and Obstetrics
  • Counseling in menopausal women: How to address the benefits and risks of menopause hormone therapy. A FIGO position paper [2024]

• International Menopause Society
  • State of the art in menopause: current best practice approaches from the IMS World Congress 2024, Melbourne [2025]
  • International Menopause Society (IMS) recommendations and key messages on women's midlife health and menopause [2025]
  • Menopause and MHT in 2024: addressing the key controversies - an International Menopause Society White Paper [2024]
  • Position Papers and Consensus Statements

• Maturitas
  • Barriers to the safe discussion of the experience and management of menopausal symptoms: A systematic literature review [2025]

• PLoS Medicine
  • Menopausal hormone therapy and women’s health: An umbrella review [2021]
  • Relationships between intensity, duration, cumulative dose, and timing of smoking with age at menopause: A pooled analysis of individual data from 17 observational studies [2018]

• Reproductive Health
  • A review of menopause nomenclature [2022]

• Sexual & Reproductive Healthcare
  • Exploring symptom clusters across the menopausal stages - systematic review and meta-analysis [2025]

Ireland

• Irish Journal of Medical Science
  • Using menopausal hormone therapy after a cancer diagnosis in Ireland [2023]

Israel

• International Journal of Women's Health
  • Healthcare Utilization and Prevalence of Symptoms in Women with Menopause: A Real-World Analysis [2020]

Italy

• BMC Women's Health
  • Informing women about hormone replacement therapy: the Consensus conference statement [2009]

Japan

• Journal of Epidemiology
  • Prevalence of the Use of Oral Contraceptives and Hormone Replacement Therapy in Japan: The Japan Nurses' Health Study [2022]

• Maturitas
  • Consultation rates, comorbidities, and prescriptions for menopausal disorders among Japanese working women: a descriptive study using a nationwide administrative insurance claims database [2026]

Latin America

• Federación Latinoamericana de Sociedades de Climaterio y Menopausia
  • Position statement of the Latin American Federation of Climacteric and Menopause Societies (FLASCYM) regarding the use of Bioidentical Hormonal Compounds during female mid-life [2024]

Low and middle income countries

• BMJ Global Health
  • Prevalence and determinants of premature or early menopause: a pooled analysis of 716 648 women from 44 low- and middle-income countries [2026]
  • Secular trends in premature and early menopause in low-income and middle-income countries [2023]

• Climacteric
  • Menopause in low and middle-income countries: a scoping review of knowledge, symptoms and management [2025]

Malaysia

• Ministry of Health Malaysia
  • Management of Menopause in Malaysia [2022]

New Zealand

• Australasian Menopause Society
  • AMS Guide to MHT/HRT Doses New Zealand only

Norway

• Human Reproduction
  • Temporal trends in age at menarche and age at menopause: a population study of 312 656 women in Norway [2020]

Poland

• Ginekologia Polska
  • Supplementation of dehydroepiandrosterone (DHEA) in pre- and postmenopausal women — position statement of expert panel of Polish Menopause and Andropause Society [2020]

• Przeglad Menopauzalny = Menopause Review
  • Position Statement by Experts of the Polish Menopause and Andropause Society on menopausal hormone therapy with an oral combination drug containing oestradiol 1 mg and progesterone 100 mg [2021]
  • Guidelines for menopausal hormone therapy: Recommendations of the Polish Menopause and Andropause Society – state of knowledge as of December 2013 [2014]

Republic of Korea

• Frontiers in Public Health
  • Trends in menopausal hormone therapy use among postmenopausal women in South Korea: analysis of KNHANES 2005-2024 [2026]

• Journal of Menopausal Medicine
  • The 2020 Menopausal Hormone Therapy Guidelines [2020]

• Lancet Regional Health – Western Pacific
  • Risk of female-specific cancers according to obesity and menopausal status in 2•7 million Korean women: Similar trends between Korean and Western women [2021]

• Scientific Reports
  • The beneficial effects of menopausal hormone therapy on renal survival in postmenopausal Korean women from a nationwide health survey [2021]

Republic of Korea, United States

• Journal of Korean Medical Science
  • Trends of Premature and Early Menopause: a Comparative Study of the US National Health and Nutrition Examination Survey and the Korea National Health and Nutrition Examination Survey [2020]

Saudi Arabia

• Council of Health Insurance
  • Menopause [2023]

Sweden

• Maturitas
  • Trends in the incidence, prevalence and sales volume of menopausal hormone therapy in Sweden from 2000 to 2021 [2023]

United Kingdom

• BMJ Open
  • Does online information about hormone replacement therapy (or menopause hormone therapy) reflect indications from the British National Formulary and guidance from the National Institute for Health and Care Excellence: a cross-sectional study of UK media [2025]

• British Gynaecological Cancer Society
  • British Gynaecological Cancer Society and British Menopause Society guidelines: Management of menopausal symptoms following treatment of gynaecological cancer [2024]

• British Journal of General Practice
  • Prescribing hormone replacement therapy: key considerations for primary care physicians [2023]
  • Socioeconomic status and HRT prescribing: a study of practice-level data in England [2020]

• British Menopause Society
  • Menopause practice standards [2024]
  • Optimising the menopause transition: Joint position statement by the British Menopause Society, Royal College of Obstetricians and Gynaecologists and Society for Endocrinology on best practice recommendations for the care of women experiencing the menopause [2022]
  • Joint position statement by the British Menopause Society, Royal College of Obstetricians and Gynaecologists and Society for Endocrinology on best practice recommendations for the care of women experiencing the menopause [2022]
  • Developing the Women's health strategy: The British Menopause Society's recommendations to the department of health and social care's call for evidence [2022]
  • British Menopause Society vision for menopause care in the UK: Endorsed by Royal College of General Practitioners, Faculty of Sexual and Reproductive Health, Royal College of Nursing, and Royal College of Obstetricians and Gynaecologists [2017]
  • BMS Tools for Clinicians

• Health Expectations
  • Women's Menopausal Experiences in the UK: A Systemic Literature Review of Qualitative Studies [2025]

• Journal of Virus Eradication
  • Menopause care in women living with HIV in the UK - A review [2022]

• National Institute for Health and Care Excellence
  • Menopause: identification and management [2026]
  • Removal, preservation and subsequent reimplantation of ovarian tissue to prevent symptoms from the menopause [2022]
  • Menopause (Quality standard) [2017]
  • Menopause

• NHS England
  • Supporting our NHS people through menopause: guidance for line managers and colleagues

• Post Reproductive Health
  • An online survey and interview of GPs in the UK for assessing their satisfaction regarding the medical training curriculum and NICE guidelines for the management of menopause [2022]

• Right Decisions
  • Menopause and HRT (Guidelines)
  • Hormone Replacement Therapy Prescribing

• Royal College of Obstetricians and Gynaecologists
  • Ovarian Cysts in Postmenopausal Women [2016]

• Women's Health
  • The evolving perspective of menopause management in the United Kingdom [2024]

United States

• Agency for Healthcare Research and Quality
  • Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force [2022]
  • Menopausal Symptoms: Comparative Effectiveness of Therapies [2015]
  • Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions [2012]

• American Association of Clinical Endocrinology
  • American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on Menopause–2017 Update [2017]

• American College of Obstetricians and Gynecologists
  • Compounded Bioidentical Menopausal Hormone Therapy [2023]

• American Society for Reproductive Medicine
  • Menopause

• Climacteric
  • Physiologic and psychosocial changes of the menopause transition in US Latinas: A narrative review [2021]

• Clinical Epigenetics
  • Timing of menarche and menopause and epigenetic aging among U.S. adults: results from the National Health and Nutrition Examination Survey 1999-2002 [2025]

• Endocrine Society
  • Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline [2015]

• Endotext
  • The Postmenopausal Women
  • Menopause and Hormone Replacement

• Food and Drug Administration
  • Estrogen and Estrogen/Progestin Drug Products to Treat Vasomotor Symptoms and Vulvar and Vaginal Atrophy Symptoms — Recommendations for Clinical Evaluation [2003]
  • Menopause: Medicines to Help You

• Frontiers in Endocrinology
  • Risks, Benefits, and Treatment Modalities of Menopausal Hormone Therapy: Current Concepts [2021]

• Hormones and Behavior
  • Not your mother's hormone therapy: Highly selective estrogen receptor beta agonists as next-generation therapies for menopausal symptom relief [2025]

• International Journal of Women's Health
  • A Review of Hormone and Non-Hormonal Therapy Options for the Treatment of Menopause [2023]

• JAMA
  • Trends in Age at Natural Menopause and Reproductive Life Span Among US Women, 1959-2018 [2021]

• JAMA Health Forum
  • Menopausal Hormone Therapy Use Among Postmenopausal Women [2024]

• Maturitas
  • Effect of menopausal hormone therapy on COVID-19 severe outcomes in women - A population-based study of the US National COVID Cohort Collaborative (N3C) data [2023]

• Menopause
  • Use of menopausal hormone therapy beyond age 65 years and its effects on women's health outcomes by types, routes, and doses [2024]
  • Treatment and resource utilization for menopausal symptoms in the United States: a retrospective review of real-world evidence from US electronic health records [2023]
  • Racial/ethnic disparities in the diagnosis and management of menopause symptoms among midlife women veterans [2022]
  • Menopausal Hormone Therapy Trends Before Versus After 2002: Impact of the Women’s Health Initiative Study Results [2018]

• National Academies of Sciences, Engineering, and Medicine
  • The Clinical Utility of Compounded Bioidentical Hormone Therapy: A Review of Safety, Effectiveness, and Use [2020]

• National Cancer Institute
  • Menopausal Hormone Therapy and Cancer

• National Institute of Child Health and Human Development
  • Menopause

• Psychoneuroendocrinology
  • Considerations and practical recommendations for identifying perimenopause in longitudinal research [2026]

• Society for Women's Health Research
  • Menopause preparedness: perspectives for patient, provider, and policymaker consideration [2021]

• StatPearls
  • Menopause
  • Hormone Replacement Therapy

• U.S. Pharmacist
  • Hormone Replacement Therapy for Menopausal Symptoms [2018]

• U.S. Preventive Services Task Force
  • Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions [2022]

WHO

• World Health Organization
  • Menopause: Fact sheet

{Related topics}

• Topic
  • Osteoporosis
  • Menopause: alternative therapy, non-hormone therapy
  • Menopause, hormone replacement therapy: hot flashes, vasomotor symptoms
  • Menopause, hormone replacement therapy: genitourinary syndrome, sexual disorders
  • Menopause, hormone replacement therapy: abnormal bleeding
  • Menopause, hormone replacement therapy, mental disorders
  • Menopause, hormone replacement therapy, cardiovascular disease
  • Menopause, hormone replacement therapy, breast cancer
  • Amenorrhea, premature ovarian insufficiency